Abatacept Trial Concludes With Favorable Results In JM Treatment

A clinical trial treating patients with juvenile myositis with the drug abatacept resulted in lower disease activity and clinically significant responses in most patients. The trial was conducted at the Cure JM Center of Excellence at George Washington University, and preliminary results were presented at the Global Conference on Myositis. Abatacept was generally well tolerated […]

Cure JM Research Consortium Receives Prestigious Chan Zuckerberg Grant

The Chan Zuckerberg Initiative has awarded Cure JM and a consortium of Cure JM-funded researchers a coveted $2 million rare disease research grant to identify new biomarkers in JM and improve precise, personalized care through the identification of cell-to-cell interactions that drive inflammation in juvenile myositis.

Cure JM’s 20th Year Opens With the Promise of Four New Research Grants

Research Grants: New Grantees and Exciting Updates From Existing Grant Recipients This year saw a very strong field of grant applications across a variety of JDM research projects. Again, we saw applications spanning the globe, recognition of the Cure JM Foundation’s preeminence in JM research, and global reach. There is a robust process to rank […]

Parent Ambassadors for Cure JM’s Giving Tuesday Holiday Challenge

Your Participation Means a Lot to Our Success We are pleased to recognize our Parent Ambassadors for Cure JM’s Giving Tuesday Holiday Challenge.  The Parent Ambassadors have stepped into a leadership role to help make the biggest day of the year a huge success for our kids. We are so grateful to all our ambassadors […]

Meet the Kania Family: Giving Tuesday Co-Chairs

Leah and PJ are parents to four-year-old daughter Olivia, who has been bravely fighting JM for almost two years. Together, they lead Cure JM’s annual Giving Tuesday Fundraiser. At the beginning of treatment, Leah and PJ felt helpless in easing Olivia’s pain—so they channeled their efforts into Cure JM.